Company intelligence / Profile preview

Porosome Therapeutics, Inc.

Boston, Massachusetts, United Statesporosome.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Porosome Therapeutics has demonstrated preclinical proof-of-concept restoring normal mucin secretion in organs affected by cystic fibrosis. Their lead program received FDA Orphan Drug Designation in early development. The company claims broad preclinical activity across multiple disease areas involving secretory dysfunction but has not reported clinical results yet.

Therapeutic areas: PulmonologyEndocrinologyImmunologyOncologyNeurology
Modalities: Small moleculesNanobodiesiPSC-derived cell therapies (beta cells)Protein/lipid reconstitution (porosome replacement)
Industry: Biotech

Drug pipeline

8 assets

AB-2

Preclinical

7 more assets in the full pipeline.

Request access →

Partnerships

Collaborations with leading scientists from academic/research institutions are mentioned but not named specifically. No major pharma partnerships disclosed yet.

Beyond the preview

Go deeper on Porosome Therapeutics, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Porosome Therapeutics, Inc..

Explore the full profile